2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow Non-small Cell Lung Cancers: new trials by email Literature Review of Non-small Cell Lung Cancers trials Research Report on Non-small Cell Lung Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers Adagrasib, Olaparib - Advanced Solid Tumor, Non-small Cell Lung Cancers | Phase 1 | Terminated | M.D. Anderson Cancer Center | 1 | 2024-01-30 | 2026-04-09 |
| PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation PRT3789, Docetaxel - Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Completed | Prelude Therapeutics Incorporated | 135 | 2023-05-02 | 2025-10-16 |
| A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors PRT3645 - Breast Cancer, Glioblastoma | Phase 1 | Completed | Prelude Therapeutics Incorporated | 22 | 2022-12-27 | 2024-07-01 |
Breast Neoplasms (1) · Endometrial Neoplasms (1) · Glioblastoma (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1) · Sarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Neoplasms (2) · Adenoma (1) · Astrocytoma (1) · Breast Diseases (1) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Glioma (1) · Head and Neck Neoplasms (1) · Lung Diseases (1) · Lung Neoplasms (1)
Docetaxel (1) · adagrasib (1) · olaparib (1)
Prelude Therapeutics Incorporated (2) · M.D. Anderson Cancer Center (1)
United States (3) · Singapore (2) · France (1) · Netherlands (1) · Spain (1)
Timothy Yap, MD (1)